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Abstract
Background: During the latter half of the natural 48-h intraerythrocytic life cycle of human Plasmodium falciparum
infection, parasites sequester deep in endothelium of tissues, away from the spleen and inaccessible to peripheral
blood. These late-stage parasites may cause tissue damage and likely contribute to clinical disease, and a more
complete understanding of their biology is needed. Because these life cycle stages are not easily sampled due to
deep tissue sequestration, measuring in vivo gene expression of parasites in the trophozoite and schizont stages
has been a challenge.
Methods: We developed a custom nCounter® gene expression platform and used this platform to measure malaria
parasite gene expression profiles in vitro and in vivo. We also used imputation to generate global transcriptional
profiles and assessed differential gene expression between parasites growing in vitro and those recovered from
malaria-infected patient tissues collected at autopsy.
Results: We demonstrate, for the first time, global transcriptional expression profiles from in vivo malaria parasites
sequestered in human tissues. We found that parasite physiology can be correlated with in vitro data from an
existing life cycle data set, and that parasites in sequestered tissues show an expected schizont-like transcriptional
profile, which is conserved across tissues from the same patient. Imputation based on 60 landmark genes generated
global transcriptional profiles that were highly correlated with genome-wide expression patterns from the same
samples measured by microarray. Finally, differential expression revealed a limited set of in vivo upregulated
transcripts, which may indicate unique parasite genes involved in human clinical infections.
Conclusions: Our study highlights the utility of a custom nCounter® P. falciparum probe set, validation of
imputation within Plasmodium species, and documentation of in vivo schizont-stage expression patterns from
human tissues.
Background
Malaria infections of humans are restricted to five species
of the Plasmodium parasite, with high morbidity associ-
ated with three of the five species and high mortality asso-
ciated predominantly with Plasmodium falciparum. These
parasites infect over 200 million and kills more than
600,000 people each year [1]. The P. falciparum genome
contains over 5,000 genes, yet more than half of these
genes encode hypothetical proteins, expanded families of
genes that interact with the immune system, and con-
served proteins of unknown function [2]. The rapid gener-
ation time of P. falciparum, wherein one parasite divides
into 16 to 24 daughter parasites within 24 to 48 h, requires
an enormous devotion of energy for cell cycle replication.
Additionally, this rapid development is precisely coordi-
nated through expression states that are predictable within
the in vitro setting over 48 h [3,4]. This predictability al-
lows for perturbations of the parasite with drugs and other
culture conditions, which can lead to global changes in
gene expression [5,6].
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blood is examined during human infection, there are
unique physiologies present that, as yet, cannot be repli-
cated in vitro [7-9]. Samples derived from human subjects
are often precious, of small volume (especially in the
pediatric setting), collected on media not suitable for trad-
itional RNA analysis (for example, filter paper, formalin
fixed paraffin embedded tissue) and, by definition, con-
taminated with human RNA. Furthermore, because para-
sites in the trophozoite and schizont stages sequester deep
in endothelium of tissues, these parasites are only access-
ible by tissue biopsy or autopsy. Previous studies with aut-
opsy tissues have measured parasite gene expression using
quantitative real-time PCR (qPCR) [10-13]. Low parasite
RNA abundance, poor quality RNA, and the presence of
human RNA in tissue with sequestered parasites have
made approaches to measure malaria gene expression in
the genome-wide scale inaccessible to date.
Spanning the middle ground between low-throughput
approaches like qPCR and high-throughput approaches
like microarrays and RNA sequencing, the Nanostring™
nCounter® platform is a middle-throughput approach
based on direct multiplex measurement of gene expres-
sion, effectively ‘counting’ transcripts using barcoded
probes and automated quantification of single molecule
digital imaging [14]. The nCounter® system works by dir-
ectly capturing and counting individual mRNA transcripts
using a target sequence bound to an immobilization bead
and possessing a unique barcode. The system is capable of
measuring gene expression with accuracy similar to qPCR,
yet nCounter® requires significantly less preparatory work
and is highly automated and capable of measuring expres-
sion in crude cell lysates. Importantly, there is no use of
reverse transcription or amplification methods prior to
measurement, eliminating amplification bias.
Here we develop and deploy two new techniques to
measure in vivo gene expression of malaria parasites se-
questered in patient tissues. Using a set of nCounter®
malaria gene probes, we quantify malaria gene expres-
sion in vivo, first in a validation set of peripheral blood
samples and then in a set of malaria-infected human tis-
sue samples collected at autopsy. We also use whole-
genome imputation to generate global transcriptional
profiles for each sample, providing a first look at the
gene expression profiles of in vivo sequestered malaria
parasites.
Methods
Probe set design
The nCounter® custom code set developed for P. falcip-
arum includes genes that were selected from a compen-
dium of existing Affymetrix and two-dye array expression
data as follows: the Affymetrix compendium consisted of
43 in vivo samples [8]; two PfSir2 knockout experiments,
each with three controls [15]; 17 samples of asexual life
cycle and three of sexual stages [16]; 23 samples of the
gametocyte life cycle [17]; five samples of a T4 drug-
treatment time course with five controls [18]; and 26
ex vivo patient samples [9]. The two-dye array compen-
dium consisted of 229 drug treatment samples [5]; 208
drug treatments, environmental stresses, and substrate de-
pletions (unpublished); and an additional 53 samples
representing an in vitro life cycle time course experiment
[4]. Genes in the nCounter® custom code set included
genes that can distinguish between intraerythrocytic life
cycle stages, highly differentially expressed genes from
previous studies [8,9], and probes representing genes of
interest expressed in gametocytes, heat shock, citric acid
cycle, glycolysis, ATP binding, ubiquitin pathways, acyl
CoA pathways, and others. Because of large sequence dif-
ferences among parasites, we excluded highly genetically
divergent gene families, such as var genes, in our initial
probe design. A total of 328 genes were selected for the
malaria nCounter® custom probe set.
nCounter® probe specificity is generated by designing
two 50 bp probes that sit next to one another, yielding
100 bp total probe specificity for each gene of interest.
Probe set design was carried out to maximize specificity
and minimize cross-hybridization. Specifically, long dir-
ect and inverted repeats and long polynucleotide repeats
were excluded, target regions were screened for cross-
hybridization against the Human RefSeq mRNA data-
base [19], and probes with stretches of more than 15
contiguous bases complementary to any non-target
mRNA were excluded. Probes were also screened for
inter- and intra-probe interactions, and were selected to
have calculated melting temperatures (Tm) between 78
and 83°C, with an ideal target of 80.5°C. Finally, mis-
match probes were also included in the nCounter® cus-
tom probe set, as part of the negative controls.
In vitro sample preparation
Serial dilutions of in vitro cultured 3D7 parasite lysates
were prepared in Qiagen RLT buffer (Catalog #79216)
with 1% beta-mercaptoethanol, and samples were stored
at -80°C prior to analysis. Mock filter paper samples were
prepared by spotting 200 uL of ring-stage parasitized red
blood cells at 33% hematocrit onto Whatman FTA filter
paper cards (GE Healthcare, Pittsburgh, PA, USA). Three
punches from each card were incubated with RNA pro-
cessing buffer (10 mM Tris-HCP, pH 8.0, 0.1 mM EDTA,
800 U/mL RNase OUT (Invitrogen), 200 ug/mL, 2 mM
DTT) for 30 min on ice, and the supernatant was passed
over a Qiagen RNeasy column (Catalog # 74104), washed
with Qiagen RPE buffer (Catalog # 1018013), and eluted
with nuclease-free water. Mock FFPE samples were pre-
pared by incubating ring-stage parasitized red blood cells
at 50% hematocrit with thrombin and bovine plasma in
Van Tyne et al. Genome Medicine 2014, 6:110 Page 2 of 9
http://genomemedicine.com/content/6/11/110sodium citrate to induce clotting. Blood clots were fixed
in 10% formalin for at least 24 h and were embedded in
paraffin wax. Four slices of five microns thickness were
deparaffinized using Qiagen deparaffinization solution
(Catalog # 19093), followed by proteinase K digestion. Pa-
tient samples were collected previously, processed for total
RNA extraction and stored at -80°C until use [9,13].
Patient samples
All patient samples used in this study were gathered
from previous studies, and their corresponding patient
demographic and sample collection information is de-
scribed in detail elsewhere [9,20]. The Institutional Re-
view Boards of the University of Malawi College of
Medicine, Albert Einstein College of Medicine, and the
Brigham and Women’sH o s p i t a lh a v ep r e v i o u s l ya p -
proved all aspects of the collection of these samples,
including obtaining informed written consent from the
parents or guardians of all patients. This research con-
forms to the ethical principles for medical research
involving human subjects put forth by the World
Medical Association Declaration of Helsinki, and to
local legislation.
Whole-genome imputation
Our imputation approach was originally developed by
Donner et al. [21]. The Affymetrix compendium de-
scribed above was curated and filtered for genes that
were present in all data sets, as well as genes that vary in
their expression across data sets. This filtered list of
3,696 genes was used as a training data set to select
landmarks and generate the imputation model. A subset
of probes, called landmarks, was selected based on their
full expression profiles within the compendium. Specific-
ally, we used the Regularized Gaussian Estimation (RGE)
method proposed by Donner et al. [21], whereby the ex-
pression of the complete probe set is modeled as a
multidimensional Gaussian set. To decide the optimal
number of probes that are needed to impute the full ex-
pression profile of each sample, we computed the model
fitting errors of models using between 10 and 100
probes. We found that an imputation model using 60
landmarks was ideal, since including additional probes
into the model beyond 60 did not yield a large improve-
ment in imputation accuracy.
Differential gene expression
Imputed nCounter® gene expression for three patients
with three different organs sampled was analyzed to de-
termine parasite genes that are overexpressed in vivo.
The three samples from each patient were compared
with 11 in vitro microarray time points with highest cor-
relation [4]. Because of differences across platforms,
both in vitro and in vivo expression data were converted
to rank-normalized values [22,23]. Differential gene ex-
pression analyses were conducted using the Limma R
package [24]. Limma is a widely used R package for dif-
ferential expression analyses of data arising from micro-
array experiments. Briefly, the method fits a linear
model to the expression data for each gene, and uses an
empirical Bayes approach to borrow information across
genes, which is equivalent to shrinkage of the estimated
sample variances towards a pooled estimate, thus mak-
ing the analyses robust even when the sample size is
small.
Statistical analysis
nCounter® platform raw data were normalized with the
NanoStringNorm R package [25], using the arithmetic
mean to summarize negative and positive controls. We also
checked the diagnostic messages from NanoStringNorm,
and confirmed that all of the samples had normalization
factors within the range of three standard deviations from
the mean. Expression analyses were based on rank-
normalized data, in order to avoid systematic variations be-
tween data sets due to differing amounts of input malaria
mRNA. We used Spearman rank correlation to make com-
parisons between nCounter® and both Affymetrix and two-
dye microarray data. To assess the relative importance of
the differential gene expression results, genes were ranked
by log-fold change, from largest to smallest. The top 100
overexpressed genes in each patient were compared, and
39 genes shared between all three patients are summarized
in Table 1.
Results
We developed a custom nCounter® malaria parasite gene
probe set containing 328 genes, which were selected from
a compendium of preexisting malaria expression micro-
array data sets (Methods). Genes selected for the probe
set included genes that can distinguish between intraery-
throcytic life cycle stages, highly differentially expressed
genes from previous in vivo studies [8,9], landmark genes
for imputation, and other genes of interest. This custom
nCounter® probe set measured P. falciparum gene expres-
sion with excellent limit of detection along a 5-log
dynamic range (Figure 1A and B). Transcripts were accur-
ately counted from as few as 6,000 parasites, a volume that
corresponds to 16 picoliters of parasitized red blood cells
at 4% parasitemia. A range of sample types were tested
and found to be suitable for analysis with nCounter®, in-
cluding parasitized red blood cells spotted onto Whatman
filter papers (Figure 1C), and formalin fixed paraffin em-
bedded tissue blocks (Figure 1D). All data are deposited
with NIH GEO (accession # GSE63260 and link: http://
www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE63260).
In vitro and in vivo parasite life cycle stages, from both
peripheral blood and human tissue, are easily and accurately
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nCounter® custom malaria platform (Figure 2, Additional
file 1). nCounter® transcript counts were compared to a
previously published in vitro life cycle time course, where
parasite transcriptional profiles were measured every hour
over the 48-h intraerythrocytic life cycle [4]. Two inde-
pendent cultures of in vitro culture-adapted 3D7 parasites,
which were synchronized and harvested at either ring
stage or schizont stage, showed peak correlation with life
cycle time points corresponding to the appropriate stage
(Figure 2A).
The same life cycle correlation method was applied to
determine parasites stages and screen peripheral blood
and fresh frozen postmortem autopsy tissue samples (see
Methods), collected from Malawian children who died of
cerebral malaria (Figure 2B, C, D), or of another cause
(Figure 2E). Parasites in peripheral blood showed the ex-
pected ring-stage profile, while parasites sequestered in
tissues from the same patient showed a schizont-stage
profile (Figure 2B). We looked for correlation between
gene expression from these tissue-sequestered parasites
and a published gametocyte expression data set [17], and
Table 1 Summary of shared malaria genes overexpressed in three in vivo patient samples
a
Category Number Description
b Gene names
Gametocyte/
Mosquito
10 Maximal expression during gametocyte or mosquito
stages
PFA0425c, PFC0581w, PFC0755c, MAL7P1.64, MAL7P1.109,
PF10_0169, PF10_0204, PF11_0163, PF13_0350, PF14_0031
Trophozoite/
Schizont
10 Maximal in vitro expression during late trophozoite or
schizont stage
PFA0210c, PFI0810c, PFI1445w, PF10_0268, PF10_0330, PF11_0048,
PF11_0156, PF11_0183, PFL1565c, PF14_0366
In vivo
expressed
7 Genes with less than 100 RPKM for any stage in vitro PFC0005w, PFI1600w, PFI1830c, PF11_0203, PFL1010c, PFL1195w,
PF14_0363
Ribosomal 6 Ribosomal or putative ribosomal proteins PFC0535w, PF11_0043, PF11_0106, PF13_0171, PF13_0213,
PF14_0027
Other 6 Maximal expression during ring/early trophozoite
stage, or conflicting stage data
PFE1370w, PF11_0111, PF11_0224, PF14_0277, PF14_0359,
PF14_0437
aThree parasite samples from each of three patients were compared with 11 in vitro microarray time points with highest correlation to each patient [4].
bLife cycle stages of maximal expression were assigned based on microarray and RNAseq data available from PlasmoDB.org.
RPKM: reads per kilobase per million mapped reads.
Figure 1 The nCounter® platform has a large dynamic range and can be used with RNA extracted from various malaria patient sample types.
(A, B) Linearity of total transcript counts versus absolute number of in vitro culture-adapted 3D7 parasites that were synchronized and isolated as (A) rings, or
(B) schizonts. Horizontal lines indicate mean transcript counts among all genes. (C, D) Processed sample transcript counts versus pre-processing lysate
transcript counts for (C) a mock filter paper sample, and (D) a mock formalin fixed paraffin embedded (FFPE) sample. (C) Culture-adapted 3D7 parasites were
synchronized and grown to ring stage, and then were spotted onto Whatman filter paper. (D) Culture-adapted 3D7 parasites were synchronized and grown
to trophozoite stage, and then parasitized red blood cells were clotted and fixed in formalin before paraffin embedding, sectioning, and processing.
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gametocyte development profiles (data not shown), sug-
gesting that intraerythrocytic stage profiles dominated in
these samples. Life cycle correlations were observed in tis-
sues where parasites were also seen by histology, and no
correlation was seen in tissues where no parasites were
found (Figure 2C). Figure 2D shows a patient in whom
parasites were observed by histology in the gut tissue, but
no life cycle correlation was detected using the nCounter®
platform, suggesting a poor quality RNA sample. Finally,
Figure 2E shows a patient that died of a cause other than
cerebral malaria. In this patient, no parasites were observed
by histology in the brain tissue, but the nCounter® platform
detected a parasite signal with strongest correlation to ring
Figure 2 P. falciparum transcriptional profiles can be measured in vitro and in vivo with nCounter® using 328 genes. (A) In vitro intraerythrocytic
gene expression measured in two different 3D7 ring-stage and schizont-stage cultures. Spearman correlations between nCounter® expression and in vitro
expression [4], is plotted versus life cycle time point. Representative illustrations of parasite developmental stages are included from [26]. (B-E) In vivo
sequestered parasite gene expression measured in postmortem blood and tissues from Malawian children that succumbed to cerebral malaria (B-D),o r
another cause of death (E). Spearman correlations between nCounter® expression and in vitro expression are plotted versus life cycle time point. Numbers
in parentheses in the legend of each panel are the number of parasites counted in 10 high-power fields by microscopy.
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sites were present in the brain microvasculature and were
collected with the brain tissue sample.
We used imputation to calculate expression values for
unknown genes using a small set of pre-defined genes
(Methods). The imputation method was validated against
parallel Affymetrix microarray data [9], and revealed that
imputation based on 60 landmark genes could accurately
approximate global transcriptional patterns, with minimal
improvement in accuracy for imputation from more than
60 genes (Figure 3A). Imputed gene expression from 52
peripheral blood samples measured with the nCounter®
platform showed good correlation with genome-wide
Affymetrix microarray data gathered from the same
Figure 3 Imputation of global expression profiles based on landmark P. falciparum genes. (A) Model fitting. Spearman rank correlations
between imputed and observed gene expression for 3,696 genes, based on imputation from varying numbers of probes. (B) Model testing.
Spearman rank correlations between imputed and observed gene expression in 52 peripheral blood RNA samples, measured with both
Affymetrix microarrays and nCounter®, before and after imputation. IAvA: imputed Affy vs. Affy (n= 3,969 genes); NvA: nCounter® vs. Affy (n=328
genes); INvA: imputed nCounter® vs. Affy (n=3,696 genes). (C) Cumulative distribution of median differences in rank abundance for 3,696 genes
between gene expression imputed from nCounter® versus Affy, averaged over 52 peripheral blood RNA samples. (D) Cumulative distribution of
Pearson correlations between imputed and measured gene expression, averaged over 52 peripheral blood RNA samples. (E) Correlation between
imputed and observed gene expression scales with expression level. Pearson correlation versus quantile-normalized and log2-transformed gene
expression for 3,696 genes averaged over 52 peripheral blood RNA samples.
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ation on a gene-by-gene basis, we examined median dif-
ferences in rank abundance (Figure 3C), and average
Pearson correlation (Figure 3D), between imputed (from
nCounter®) and observed (Affymetrix) expression of each
gene among the 52 peripheral blood samples. Approxi-
mately 65% of imputed genes had a median difference in
rank abundance lower than 500 (Figure 3C), and roughly
70% of genes had an average Pearson correlation above
0.3 (Figure 3D). Finally, the strength of correlation be-
tween imputed and observed values scaled with gene ex-
pression (Figure 3E), with more highly expressed genes
having higher correlations and more lowly expressed
genes having lower correlations.
We used the nCounter® platform and global imput-
ation to ask whether in vivo parasite samples cluster by
organ or by patient (Figure 4), and to detect genes that
are overexpressed by parasites sequestered in human tis-
sues (Table 1). Hierarchical clustering of in vivo seques-
tered parasites from autopsy tissue samples showed that
samples cluster by patient, rather than by organ, regard-
less of whether clustering is based on gene expression
measured by the nCounter® platform (Figure 4A), or
imputed gene expression (Figure 4B). Differential gene
expression analysis between rank-normalized imputed
in vivo and in vitro microarray data revealed a shared set
of 39 genes that were among the top 100 overexpressed
genes in all three of the analyzed patients (Table 1). This
set of in vivo overexpressed genes included 10 genes
with maximal expression during sexual and mosquito
stages, 10 genes with maximal in vitro expression during
trophozoite and schizont stages, seven genes that are
not expressed in vitro, and six genes that code for ribo-
somal proteins. These data indicate that parasites se-
questered in human tissues may exist in a unique
physiological state.
Discussion
The development of new tools and adaptation of existing
tools for use by malaria researchers and clinicians to meet
elimination and eradication goals is a priority. Ideal tools
should give maximal information from minimal amounts of
biological sample, and be both affordable and easy to use.
Our goal is to develop and deploy such tools for global use
by the malaria community. Here we show how adaptation
of two existing tools - the nCounter® platform and imput-
ation of global gene expression - can be leveraged to un-
cover the expression profiles of in vivo sequestered malaria
parasites. These unique transcriptional profiles have, until
now, been impossible to measure on a global scale.
Although sequencing and array technologies are sen-
sitive and thorough, deployment of such techniques to
field settings, contamination of human mRNA, and/or
cost inefficiency of these tools as screening methods
make their usefulness limited for immediate screening
and characterization of large numbers of samples. By
measuring just 328 parasite genes, we were able to dis-
tinguish between asexual life cycle stages using picoliter
volumes of infected red blood cells. Moreover, we could
classify parasite physiological states quickly and as
Figure 4 In vivo parasite gene expression clusters by patient. (A) Hierarchical clustering of expression of 328 genes measured by nCounter®
from 13 tissue samples collected at autopsy, collected from five patients and three organs. Clustering demonstrates that samples cluster by
patient, rather than by organ, suggesting that parasite physiology within a patient is conserved. (B) Hierarchical clustering of global expression
profiles imputed from nCounter® (n=3,696 genes) shows that within-patient clusters remain intact. Note that two outliers in the first analysis (P1,
Brain and P2, Heart) are further delineated as true outliers after imputation.
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nCounter® platform and our custom P. falciparum
probe set could be a valuable screening method to as-
sess RNA quality in crude lysate samples and determine
parasite life cycle stages, both of which are useful to
identify meaningful groups of samples for more costly
and labor intensive experiments, such as RNAseq.
Because both human [21] and malaria parasite [7-9]
physiologic expression states are predictable, they can be ac-
curately determined using subsets of carefully selected land-
mark genes. Full-scale prediction of global expression
profiles using established imputation methods allowed us to
query the expression of nearly 3,700 genes from just 60
landmarks. When we compared imputed expression profiles
with expression data from the same RNA samples measured
with microarrays, we found that correlations between im-
puted and observed expression were only slightly lower than
cross-platform correlations performed without imputation
(Figure 3B). Nonetheless, genes that were lowly expressed in
all samples showed poor correlations between imputed and
observed expression across the 52 samples we used to test
the imputation model (Figure 3E). For this reason, imput-
ation is intended as a screening approach, which can be
utilized in picking samples for more comprehensive experi-
ments such as RNAseq. Data from further studies of para-
site physiology will be useful for refining the imputation
model, to incorporate additional variation and more accur-
ately impute lowly expressed genes.
Previous studies have applied nCounter® to other in-
fectious diseases [27-29], however this is the first appli-
cation to measure malaria parasite physiological states
in vivo. We found that parasites sequestered in human
tissue overexpress genes that are enriched during gam-
etocyte and mosquito stages, as well as genes that are
not normally expressed in vitro. We also found that
sample clustered largely by patient, with differences be-
tween samples from the same patient likely due to differ-
ent time points of sample collection. Although it is
possible that differences in genetic makeup of parasites
in an organ could result in different expression patterns
within the same patient, our previous data have shown
that genotypes are largely conserved across organs [30].
Examination by gene set enrichment analysis (GSEA) of
our imputed samples also revealed overexpression of
gametocyte genes, but these findings were not statisti-
cally significant (data not shown). Importantly, many of
the shared overexpressed in vivo genes encode con-
served proteins of unknown function, indicating unex-
plored areas of parasite physiology that are relevant
in vivo. Using additional data sets and collaborations
with others in the malaria community, future custom
nCounter® arrays can be designed to study specific gene
sets, at costs comparable to qPCR but with massive sav-
ings of both time and throughput.
Conclusions
In this study, we used a custom P. falciparum nCounter®
probe set to measure malaria parasite gene expression in
a variety of samples derived from both in vitro experi-
ments and in vivo human infections, using very small
amounts of mRNA. We used newly developed imput-
ation methods to predict the global expression profiles
of samples by measuring only a subset of genes. We ap-
plied these methods to study the in vivo transcriptional
profiles of parasites sequestered within the tissues of
Malawian children who succumbed to cerebral malaria.
For the first time, we measured the expression profiles
of sequestered schizont-stage parasites within a human
infection. The nCounter® platform is of great utility to
the malaria community, as it is amenable to many differ-
ent types of samples, and imputation allows researchers
to measure a small number of genes and gain an under-
standing of global expression patterns.
Additional file
Additional file 1: Lists processed (normalized and log2-transformed)
nCounter® data for all in vivo patient samples presented.
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